Moderna reveals detailed plans for Covid-19 clinical trial

Washington (AFP) – US biotech firm Moderna, one of two companies currently holding phase 3 trials in the United States for a Covid-19 vaccine, took the unusual step Thursday of publishing its trial protocols after calls for more transparency.The race for a vaccine has taken a political turn in the run-up to the November 3 election, with President Donald Trump regularly promising to have one brought to market by October, raising questions about possible pressure on the Food and Drug Administration (FDA) to move quickly.Experts and even officials from his own administration say the outcome of on…

Read More

HEDGE accordingly